LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 48.65 | 84.90 | 649 | 5328 | 0.1218 | 0.4058 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 48.65 | 84.90 | 4454 | 5328 | 0.8358 | 0.9408 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 50.36 | 84.90 | 5275 | 5651 | 0.9335 | 0.9774 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 50.36 | 84.90 | 5335 | 5651 | 0.9441 | 0.9811 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 50.36 | 84.90 | 668 | 5651 | 0.1182 | 0.4058 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 50.36 | 84.90 | 4718 | 5651 | 0.8349 | 0.9413 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 52.06 | 84.90 | 5629 | 5990 | 0.9396 | 0.9798 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 52.06 | 84.90 | 5687 | 5990 | 0.9493 | 0.9831 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 52.06 | 84.90 | 741 | 5990 | 0.1237 | 0.4231 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 52.06 | 84.90 | 5030 | 5990 | 0.8396 | 0.9439 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 53.77 | 84.90 | 5904 | 6252 | 0.9442 | 0.9816 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 53.77 | 84.90 | 5994 | 6252 | 0.9586 | 0.9864 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 53.77 | 84.90 | 788 | 6252 | 0.1260 | 0.4322 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 53.77 | 84.90 | 5298 | 6252 | 0.8473 | 0.9473 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 55.48 | 84.90 | 6247 | 6567 | 0.9512 | 0.9841 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 55.48 | 84.90 | 6309 | 6567 | 0.9606 | 0.9872 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 55.48 | 84.90 | 800 | 6567 | 0.1218 | 0.4298 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 55.48 | 84.90 | 5685 | 6567 | 0.8656 | 0.9545 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 57.18 | 84.90 | 6471 | 6963 | 0.9293 | 0.9771 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 57.18 | 84.90 | 6571 | 6963 | 0.9437 | 0.9818 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 57.18 | 84.90 | 795 | 6963 | 0.1142 | 0.4217 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 57.18 | 84.90 | 6053 | 6963 | 0.8693 | 0.9564 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 58.88 | 84.90 | 6666 | 7291 | 0.9142 | 0.9723 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 58.88 | 84.90 | 6855 | 7291 | 0.9401 | 0.9809 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 58.88 | 84.90 | 782 | 7291 | 0.1072 | 0.4129 | MN20160318_Q02 | D15 |